The FOXL2 gene gives cells instructions for a protein that helps control how other genes are switched on and off. This gene plays an important role in the normal development of the eyelids and ovaries. If it does not work properly, a person may be born with narrowed eye openings and drooping eyelids, and some may later develop reduced ovarian function or early menopause. Changes in this gene can also be found in some rare ovarian tumors.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
FOXL2Gene function
What if the gene works
The FOXL2 gene helps guide early eyelid formation and supports the ovaries, especially cells that nurture eggs and help regulate hormone production.
Risk
What if the gene does not work
FOXL2 variants most often cause changes in eyelid development, and some also affect ovarian function, leading to early menopause. Effects can range from milder to more severe. A specific acquired FOXL2 variant is strongly linked to adult granulosa cell tumors.
Treatment
What does that mean for your treatment
No FOXL2-specific treatment or drug-choice approach is currently established in clinical guidelines. In practice, care is based on the features a person has, and the FOXL2 gene is being studied mainly as a biomarker in adult granulosa cell tumors rather than as a guide to a proven targeted therapy.
Conditions associated with FOXL2
Gene function
What if the gene works
The FOXL2 gene helps certain tissues develop and keep their normal identity over time. It is especially important in the ovaries and in the tissues that form the eyelids. Its protein acts like a control switch, turning many other genes on or off so cells follow the right plan.
FOXL2 makes a protein that works like a gene switch. It helps turn selected genes on or off so cells can grow, mature, and do their usual jobs in an organized way.
In the ovary, the FOXL2 gene helps granulosa cells (support cells around the egg) do their daily work. This supports a healthy environment for the egg and helps the ovary keep its usual female pattern over time.
This gene helps guide the growth of follicles (small sacs that hold developing eggs). It keeps the timing and behavior of nearby support cells coordinated as the egg matures.
Early in development, the FOXL2 gene helps guide the tissues that form the eyelids. This supports the normal shaping and joining of the lids before birth.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the FOXL2 gene change the protein's shape, stability, or ability to attach to DNA and guide gene activity. Some small spelling changes leave part of its activity in place, while more disruptive variants, including deletions or early stop variants, can lead to little or no working protein. This range helps explain how FOXL2 gene variants affect protein function and why some people with BPES have milder eyelid findings, while others are more likely to have ovarian involvement.
How variants are linked to conditions
Inherited pathogenic variants in the FOXL2 gene cause blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES), a condition that mainly affects eyelid development. In clinical genetics, variants in the FOXL2 gene linked to BPES are also connected with premature ovarian insufficiency in some people with ovaries. Separately, a specific acquired FOXL2 variant is strongly associated with adult granulosa cell tumor of the ovary.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited FOXL2-related conditions, risk is driven mainly by whether a disease-causing FOXL2 variant is present in a family. Lifestyle factors are not known to meaningfully change the chance of having the eyelid features, and some FOXL2 variants also raise the chance of reduced ovarian function or early menopause.
Inheritance of FOXL2 variants
FOXL2-related blepharophimosis, ptosis, and epicanthus inversus syndrome is usually inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the FOXL2 gene has a 50% chance of passing it on to each child, regardless of sex. Some people have a new, de novo variant in the FOXL2 gene, meaning it was not inherited from either parent. When people ask about inheritance of the FOXL2 gene variants, this autosomal dominant pattern is the main one linked to the well-established inherited condition.
What does my FOXL2 result mean for my family?
A disease-causing FOXL2 result is most often linked to a dominant condition called blepharophimosis-ptosis-epicanthus inversus syndrome, so close relatives such as a parent, brother, sister, or child may also carry the same change. Each child of someone with a disease-causing FOXL2 variant has a 1 in 2, or 50%, chance of inheriting it. In some families, the variant is new in one person, so it is not always passed down from a parent.
Genetic information
Genetic testing
How you find out about variants
FOXL2 genetic testing uses blood, saliva, or a swab to look for variants. To explain how FOXL2 genetic testing works, a lab reads the FOXL2 gene and checks for changes linked with blepharophimosis ptosis epicanthus inversus syndrome or an adult granulosa cell tumor. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider FOXL2 genetic testing if you or your child has a typical eyelid pattern present from birth, such as very narrow eye openings and droopy lids, especially if it runs in the family. Testing may also help when these eye changes occur along with ovaries stopping early, which can lead to infertility or menopause at a young age.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but what they show depends on the condition and on the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes can shape the way people respond to medications. It examines gene drug patterns to help explain why the same treatment may affect one person differently than another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can help guide more informed and individualized treatment decisions. If you want to learn more about this topic, you can read more in the LearnHub.
Drugs influenced by the FOXL2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. For questions about side effects, how well a medicine is working, or changes to treatment, talk with your doctor or pharmacist.
History
FOXL2 entered the medical literature through studies of families with blepharophimosis ptosis epicanthus inversus syndrome, a condition affecting eyelid development that had been recognized long before the gene itself was identified. In 2001, researchers linked this condition to changes in the FOXL2 gene, marking an important step in understanding inherited causes of these facial features and, in some families, early ovarian insufficiency. From these first observations, research expanded steadily. A major milestone came in 2009, when a recurring FOXL2 variant, c.402C>G, was found in many adult granulosa cell tumors of the ovary. That finding made FOXL2 especially important in both clinical genetics and tumor pathology, and it remains a key part of how this rare tumor type is studied today.